Citation

Yamaguchi T, Sugimoto T. Clin. Calcium 2014; 24(3): 349-355.

Affiliation

Internal Medicine 1, Shimane University Faculty of Medicine, Japan.

Copyright

(Copyright © 2014, Iyanku Journal Company)

DOI

CliCa1403349355

PMID

24576931

Abstract

Accumulating evidence shows that type 2 diabetes and chronic kidney disease (CKD) enhance fracture risk mainly by deteriorating bone quality. Vertebral fracture on X-ray films and hip fracture in past history in subjects of 50 years old or more are hallmarks to start medication for osteoporosis. Patients with diabetes or CKD who have no fracture could undergo drug treatments if their bone mineral density is osteopenic, considering the established link between these disorders and fracture risk.

Language: ja